A. Onat And G. Hergenc, "Reduced asymmetric dimethylarginine (ADMA) levels mediate in the protection from metabolic syndrome by smoking," ATHEROSCLEROSIS , vol.196, no.1, pp.479-480, 2008
Onat, A. And Hergenc, G. 2008. Reduced asymmetric dimethylarginine (ADMA) levels mediate in the protection from metabolic syndrome by smoking. ATHEROSCLEROSIS , vol.196, no.1 , 479-480.
Onat, A., & Hergenc, G., (2008). Reduced asymmetric dimethylarginine (ADMA) levels mediate in the protection from metabolic syndrome by smoking. ATHEROSCLEROSIS , vol.196, no.1, 479-480.
Onat, Altan, And Guelay Hergenc. "Reduced asymmetric dimethylarginine (ADMA) levels mediate in the protection from metabolic syndrome by smoking," ATHEROSCLEROSIS , vol.196, no.1, 479-480, 2008
Onat, Altan And Hergenc, Guelay. "Reduced asymmetric dimethylarginine (ADMA) levels mediate in the protection from metabolic syndrome by smoking." ATHEROSCLEROSIS , vol.196, no.1, pp.479-480, 2008
Onat, A. And Hergenc, G. (2008) . "Reduced asymmetric dimethylarginine (ADMA) levels mediate in the protection from metabolic syndrome by smoking." ATHEROSCLEROSIS , vol.196, no.1, pp.479-480.
@article{article, author={Altan Onat And author={Guelay Hergenc}, title={Reduced asymmetric dimethylarginine (ADMA) levels mediate in the protection from metabolic syndrome by smoking}, journal={ATHEROSCLEROSIS}, year=2008, pages={479-480} }